Endobronchial Valves in the Management of Persistent Air Leak in Coronavirus Disease 2019.


Journal

The Annals of thoracic surgery
ISSN: 1552-6259
Titre abrégé: Ann Thorac Surg
Pays: Netherlands
ID NLM: 15030100R

Informations de publication

Date de publication:
01 2022
Historique:
received: 16 05 2021
revised: 28 07 2021
accepted: 03 08 2021
pubmed: 8 9 2021
medline: 14 1 2022
entrez: 7 9 2021
Statut: ppublish

Résumé

Pneumothorax and persistent air leak are documented complications of severe acute respiratory syndrome coronavirus 2 infection. Patients who fall into this category are often poor candidates for invasive thoracic surgical intervention. Endobronchial valves offer an effective and less invasive treatment option and can successfully treat persistent air leak and support the weaning of patients with severe acute respiratory syndrome coronavirus 2 pneumonia off ventilation.

Identifiants

pubmed: 34492216
pii: S0003-4975(21)01557-5
doi: 10.1016/j.athoracsur.2021.08.011
pmc: PMC8418015
pii:
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1-e3

Informations de copyright

Copyright © 2022 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Auteurs

Hanad Ahmed (H)

Department of Thoracic Surgery, University Hospital Southampton, Southampton, United Kingdom.

Abdul Badran (A)

Department of Thoracic Surgery, University Hospital Southampton, Southampton, United Kingdom.

Alessandro Tamburrini (A)

Department of Thoracic Surgery, University Hospital Southampton, Southampton, United Kingdom.

Hassan Kattach (H)

Department of Thoracic Surgery, University Hospital Southampton, Southampton, United Kingdom.

Lukacs Veres (L)

Department of Thoracic Surgery, University Hospital Southampton, Southampton, United Kingdom.

Aiman Alzetani (A)

Department of Thoracic Surgery, University Hospital Southampton, Southampton, United Kingdom. Electronic address: aiman.alzetani@uhs.nhs.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH